These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 16460675)

  • 21. Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen.
    Kelly-Cirino CD; Mantis NJ
    Infect Immun; 2009 Nov; 77(11):4859-67. PubMed ID: 19703971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen.
    Oscherwitz J; Quinn CP; Cease KB
    Vaccine; 2015 May; 33(20):2342-6. PubMed ID: 25820066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
    Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
    Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model.
    Zhao P; Liang X; Kalbfleisch J; Koo HM; Cao B
    Hum Antibodies; 2003; 12(4):129-35. PubMed ID: 15156101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection.
    Hepler RW; Kelly R; McNeely TB; Fan H; Losada MC; George HA; Woods A; Cope LD; Bansal A; Cook JC; Zang G; Cohen SL; Wei X; Keller PM; Leffel E; Joyce JG; Pitt L; Schultz LD; Jansen KU; Kurtz M
    Vaccine; 2006 Mar; 24(10):1501-14. PubMed ID: 16271808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric hepatitis B virus core particles carrying an epitope of anthrax protective antigen induce protective immunity against Bacillus anthracis.
    Yin Y; Zhang J; Dong D; Liu S; Guo Q; Song X; Li G; Fu L; Xu J; Chen W
    Vaccine; 2008 Oct; 26(46):5814-21. PubMed ID: 18786589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the immune response induced by a nasal anthrax vaccine based on the protective antigen protein in anaesthetized and non-anaesthetized mice.
    Sloat BR; Cui Z
    J Pharm Pharmacol; 2006 Apr; 58(4):439-47. PubMed ID: 16597361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
    Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
    Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.
    Moayeri M; Leysath CE; Tremblay JM; Vrentas C; Crown D; Leppla SH; Shoemaker CB
    J Biol Chem; 2015 Mar; 290(10):6584-95. PubMed ID: 25564615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen.
    Ogasawara Y; Amexis G; Yamaguchi H; Kajigaya S; Leppla SH; Young NS
    In Vivo; 2006; 20(3):319-24. PubMed ID: 16724664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen.
    Gubbins MJ; Berry JD; Corbett CR; Mogridge J; Yuan XY; Schmidt L; Nicolas B; Kabani A; Tsang RS
    FEMS Immunol Med Microbiol; 2006 Aug; 47(3):436-43. PubMed ID: 16872381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens.
    Sloat BR; Shaker DS; Le UM; Cui Z
    FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli.
    Sloat BR; Cui Z
    Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activity of the Bacillus anthracis 20 kDa protective antigen component.
    Hammamieh R; Ribot WJ; Abshire TG; Jett M; Ezzell J
    BMC Infect Dis; 2008 Sep; 8():124. PubMed ID: 18808698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selection of human antibodies against cell surface-associated oligomeric anthrax protective antigen.
    Steiniger SC; Altobell LJ; Zhou B; Janda KD
    Mol Immunol; 2007 Apr; 44(10):2749-55. PubMed ID: 17210180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Membrane insertion by anthrax protective antigen in cultured cells.
    Qa'dan M; Christensen KA; Zhang L; Roberts TM; Collier RJ
    Mol Cell Biol; 2005 Jul; 25(13):5492-8. PubMed ID: 15964805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epitope mapping of the protective antigen of B. anthracis by using nanoclusters presenting conformational peptide epitopes.
    Gerdon AE; Wright DW; Cliffel DE
    Angew Chem Int Ed Engl; 2006 Jan; 45(4):594-8. PubMed ID: 16355420
    [No Abstract]   [Full Text] [Related]  

  • 40. Mapping the epitopes of a neutralizing antibody fragment directed against the lethal factor of Bacillus anthracis and cross-reacting with the homologous edema factor.
    Thullier P; Avril A; Mathieu J; Behrens CK; Pellequer JL; Pelat T
    PLoS One; 2013; 8(5):e65855. PubMed ID: 23741517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.